PT Suparma Tbk (ISX:SPMA) Other Current Liabilities: Rp3,028 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SPMA PT Suparma Tbk ISX:SPMA
77 GF Score
Price Rp170.00
GF Value Rp183.70
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is PT Suparma Tbk Other Current Liabilities?

PT Suparma Tbk ISX:SPMA 77 Other Current Liabilities is Rp3,028 Mil as of Mar. 2026. GuruFocus rates ISX:SPMA with a GF Score™ of 77/100 and a GF Value™ of Rp183.70 (Fairly Valued). The stock has 6 warning signs investors should review.

PT Suparma Tbk's other current liabilities for the quarter that ended in Mar. 2026 was Rp3,028 Mil.

PT Suparma Tbk's quarterly other current liabilities increased from Sep. 2025 (Rp1,636 Mil) to Dec. 2025 (Rp2,056 Mil) and increased from Dec. 2025 (Rp2,056 Mil) to Mar. 2026 (Rp3,028 Mil).

PT Suparma Tbk's annual other current liabilities increased from Dec. 2023 (Rp2,295 Mil) to Dec. 2024 (Rp2,911 Mil) but then declined from Dec. 2024 (Rp2,911 Mil) to Dec. 2025 (Rp2,056 Mil).

PT Suparma Tbk Other Current Liabilities Related Terms

PT Suparma Tbk Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for PT Suparma Tbk's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Suparma Tbk Other Current Liabilities Chart

PT Suparma Tbk Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only 904.85 1,939.45 2,295.08 2,910.60 2,056.34

PT Suparma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,975.90 1,391.74 1,635.75 2,056.34 3,027.72
ISX:SPMA
77GF Score
PT Suparma Tbk ISX:SPMA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Suparma Tbk Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of Rp3,028 Mil mean?
PT Suparma Tbk (ISX:SPMA) has a Other Current Liabilities of Rp3,028 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PT Suparma Tbk.
Is PT Suparma Tbk's Other Current Liabilities too high?
PT Suparma Tbk's current Other Current Liabilities is Rp3,028 Mil. Overall, PT Suparma Tbk has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Suparma Tbk's Other Current Liabilities compare to SLVM?
PT Suparma Tbk's Other Current Liabilities of Rp3,028 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Forest Products company?
A good Other Current Liabilities depends on the Forest Products industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PT Suparma Tbk. PT Suparma Tbk's current Other Current Liabilities is Rp3,028 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Suparma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Suparma Tbk (ISX:SPMA) is currently considered Fairly Valued. The stock's GF Value™ is Rp183.70, compared to a current price of Rp170.00 — trading 7.5% below its estimated fair value. The current Other Current Liabilities is Rp3,028 Mil. PT Suparma Tbk's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For PT Suparma Tbk (ISX:SPMA), the current Other Current Liabilities is Rp3,028 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Suparma Tbk (ISX:SPMA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Suparma Tbk stock appears to be undervalued. The current stock price of Rp170.00 is trading 7.5% below its estimated GF Value™ of Rp183.70. GuruFocus considers PT Suparma Tbk to be Fairly Valued.

Key valuation signals for ISX:SPMA:

  • Other Current Liabilities: Rp3,028 Mil
  • GF Value™: Rp183.70 vs. price of Rp170.00 (7.5% below fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the ISX:SPMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Suparma Tbk Business Description

Address Jalan Raya Mastrip, No. 856 Warugunung, Karangpilang, East Java, Surabaya, IDN, 60221
PT Suparma Tbk is an Indonesia-based company that manufactures paper and paper products. The group manufactured paper and paper wrapping products for the industrial and consumer sectors. The firm offers Laminated Wrapping Kraft, Samson Kraft, MG Paper, Coated Duplex Board, Bathroom Tissue, Carrier Tissue, Industrial Roll Towel, Kitchen Towel, and Other products. Geographically, the firm generates the majority of its revenue from the local market.
77GF Score

Get the complete analysis for ISX:SPMA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp170.00
Price
Rp183.70
GF Value